Literature DB >> 33853964

Nucleolin Promotes IRES-Driven Translation of Foot-and-Mouth Disease Virus by Supporting the Assembly of Translation Initiation Complexes.

Shichong Han1,2,3, Xiaojia Wang2, Junyong Guan1, Jinen Wu1, Yun Zhang1, Pinghua Li1, Zaixin Liu1, Sahibzada Waheed Abdullah1, Zhihui Zhang1, Ye Jin1, Shiqi Sun1, Huichen Guo1,4.   

Abstract

Nucleolin (NCL), a stress-responsive RNA-binding protein, has been implicated in the translation of internal ribosome entry site (IRES)-containing mRNAs, which encode proteins involved in cell proliferation, carcinogenesis, and viral infection (type I IRESs). However, the details of the mechanisms by which NCL participates in IRES-driven translation have not hitherto been described. Here, we identified NCL as a protein that interacts with the IRES of foot-and-mouth disease virus (FMDV), which is a type II IRES. We also mapped the interactive regions within FMDV IRES and NCL in vitro. We found that NCL serves as a substantial regulator of FMDV IRES-driven translation but not of bulk cellular or vesicular stomatitis virus cap-dependent translation. NCL also modulates the translation of and infection by Seneca Valley virus (type III-like IRES) and classical swine fever virus (type III IRES), which suggests that its function is conserved in unrelated IRES-containing viruses. We also show that NCL affects viral replication by directly regulating the production of viral proteins and indirectly regulating FMDV RNA synthesis. Importantly, we observed that the cytoplasmic relocalization of NCL during FMDV infection is a substantial step for viral IRES-driven translation and that NCL specifically promotes the initiation phase of the translation process by recruiting translation initiation complexes to viral IRES. Finally, the functional importance of NCL in FMDV pathogenicity was confirmed in vivo. Taken together, our findings demonstrate a specific function for NCL in selective mRNA translation and identify a target for the development of a broad-spectrum class of antiviral interventions. IMPORTANCE FMDV usurps the cellular translation machinery to initiate viral protein synthesis via a mechanism driven by IRES elements. It allows the virus to shut down bulk cellular translation, while providing an advantage for its own gene expression. With limited coding capacity in its own genome, FMDV has evolved a mechanism to hijack host proteins to promote the recruitment of the host translation machinery, a process that is still not well understood. Here, we identified nucleolin (NCL) as a positive regulator of the IRES-driven translation of FMDV. Our study supports a model in which NCL relocalizes from the nucleus to the cytoplasm during the course of FMDV infection, where the cytoplasmic NCL promotes FMDV IRES-driven translation by bridging the translation initiation complexes with viral IRES. Our study demonstrates a previously uncharacterized role of NCL in the translation initiation of IRES-containing viruses, with important implications for the development of broad antiviral interventions.

Entities:  

Keywords:  IRES; RNA-binding protein; foot-and-mouth disease virus; internal ribosome entry site; nucleolin; selective viral translation; translation initiation

Mesh:

Substances:

Year:  2021        PMID: 33853964      PMCID: PMC8315980          DOI: 10.1128/JVI.00238-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells.

Authors:  G J Belsham; G M McInerney; N Ross-Smith
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Heterogeneous Nuclear Ribonucleoprotein L Negatively Regulates Foot-and-Mouth Disease Virus Replication through Inhibition of Viral RNA Synthesis by Interacting with the Internal Ribosome Entry Site in the 5' Untranslated Region.

Authors:  Chao Sun; Mengmeng Liu; Jitao Chang; Decheng Yang; Bo Zhao; Haiwei Wang; Guohui Zhou; Changjiang Weng; Li Yu
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

3.  Nucleolin interacts with US11 protein of herpes simplex virus 1 and is involved in its trafficking.

Authors:  Anna Greco; Loredana Arata; Eric Soler; Xavier Gaume; Yohann Couté; Sabine Hacot; Aleth Callé; Karine Monier; Alberto L Epstein; Jean-Charles Sanchez; Philippe Bouvet; Jean-Jacques Diaz
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

4.  Structural analysis of the interaction of the pyrimidine tract-binding protein with the internal ribosomal entry site of encephalomyocarditis virus and foot-and-mouth disease virus RNAs.

Authors:  V G Kolupaeva; C U Hellen; I N Shatsky
Journal:  RNA       Date:  1996-12       Impact factor: 4.942

5.  Nucleolin enhances internal ribosomal entry site (IRES)-mediated translation of Sp1 in tumorigenesis.

Authors:  Chia-Yang Hung; Wen-Bin Yang; Shao-An Wang; Tsung-I Hsu; Wen-Chang Chang; Jan-Jong Hung
Journal:  Biochim Biophys Acta       Date:  2014-08-27

Review 6.  The mechanism of eukaryotic translation initiation and principles of its regulation.

Authors:  Richard J Jackson; Christopher U T Hellen; Tatyana V Pestova
Journal:  Nat Rev Mol Cell Biol       Date:  2010-02       Impact factor: 94.444

Review 7.  Hepatitis C virus RNA translation.

Authors:  Michael Niepmann
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

8.  Dynamic and nucleolin-dependent localization of human cytomegalovirus UL84 to the periphery of viral replication compartments and nucleoli.

Authors:  Brian J Bender; Donald M Coen; Blair L Strang
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

9.  Nucleolin interacts with several ribosomal proteins through its RGG domain.

Authors:  P Bouvet; J J Diaz; K Kindbeiter; J J Madjar; F Amalric
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

10.  Additive Promotion of Viral Internal Ribosome Entry Site-Mediated Translation by Far Upstream Element-Binding Protein 1 and an Enterovirus 71-Induced Cleavage Product.

Authors:  Chuan-Tien Hung; Yu-An Kung; Mei-Ling Li; Gary Brewer; Kuo-Ming Lee; Shih-Tung Liu; Shin-Ru Shih
Journal:  PLoS Pathog       Date:  2016-10-25       Impact factor: 6.823

View more
  7 in total

Review 1.  Phase Separation of Intrinsically Disordered Nucleolar Proteins Relate to Localization and Function.

Authors:  Francisco Guillen-Chable; Andrea Bayona; Luis Carlos Rodríguez-Zapata; Enrique Castano
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

Review 2.  RNA-Binding Proteins as Regulators of Internal Initiation of Viral mRNA Translation.

Authors:  Brenda López-Ulloa; Yazmín Fuentes; Magdalena S Pizarro-Ortega; Marcelo López-Lastra
Journal:  Viruses       Date:  2022-01-19       Impact factor: 5.048

3.  Seneca Valley Virus 3Cpro Mediates Cleavage and Redistribution of Nucleolin To Facilitate Viral Replication.

Authors:  Jiangwei Song; Rong Quan; Dan Wang; Jue Liu
Journal:  Microbiol Spectr       Date:  2022-03-31

Review 4.  Picornavirus translation strategies.

Authors:  Rosario Francisco-Velilla; Azman Embarc-Buh; Salvador Abellan; Encarnacion Martinez-Salas
Journal:  FEBS Open Bio       Date:  2022-03-30       Impact factor: 2.792

5.  Interaction of Nucleolin with the Fusion Protein of Avian Metapneumovirus Subgroup C Contributes to Viral Replication.

Authors:  Dedong Wang; Lei Hou; Ning Zhu; Xiaoyu Yang; Jianwei Zhou; Yongqiu Cui; Jinshuo Guo; Xufei Feng; Jue Liu
Journal:  Viruses       Date:  2022-06-27       Impact factor: 5.818

6.  DDX21, a Host Restriction Factor of FMDV IRES-Dependent Translation and Replication.

Authors:  Sahibzada Waheed Abdullah; Jin'en Wu; Yun Zhang; Manyuan Bai; Junyong Guan; Xiangtao Liu; Shiqi Sun; Huichen Guo
Journal:  Viruses       Date:  2021-09-03       Impact factor: 5.048

Review 7.  Circular RNAs' cap-independent translation protein and its roles in carcinomas.

Authors:  Lian He; Changfeng Man; Shouyan Xiang; Lin Yao; Xiaoyan Wang; Yu Fan
Journal:  Mol Cancer       Date:  2021-09-15       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.